Late-stage clinical development of Chikungunya vaccines in endemic countries (CHIKV) and Controlled Human Infection Models for SARS-CoV2 and other beta coronaviruses (CHIM).

Projektinformationen

CHIKVAX_CHIM

ID Finanzhilfevereinbarung: 101126531

DOI 10.3030/101126531

EK-Unterschriftsdatum 15 Juni 2023

Startdatum 1 Juni 2023

Enddatum 30 November 2028

Finanziert unter

• Health

Gesamtkosten € 100 000 000,00

EU-Beitrag € 70 000 000,00

Koordiniert durch

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Norway

Leistungen

Websites, patent fillings, videos etc. (2)

CHIM CfP publication on CEPI website

Publication on CEPI website of the CHIM Call for Proposals due on month 3

CHIK Vaccine CfP publication on CEPI website

Publication of the CHIK Vaccine call for proposals CfP on CEPIs website